Smith & Nephew plc ADR Stock
Smith & Nephew plc ADR Stock
The price for the Smith & Nephew plc ADR stock decreased slightly today. Compared to yesterday there is a change of -€0.200 (-0.770%).
Pros and Cons of Smith & Nephew plc ADR in the next few years
Pros
?
M***** P*******
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Smith & Nephew plc ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Smith & Nephew plc ADR | -0.770% | 0.000% | -5.147% | -18.354% | -7.857% | 3.200% | -19.876% |
| Smith & Nephew plc | -0.770% | 0.000% | -4.444% | -17.334% | -9.251% | 2.097% | -21.413% |
| Boston Scientific | -0.900% | 1.647% | 15.478% | -49.626% | -45.418% | -5.165% | 15.223% |
| Humana Inc. | -1.180% | -1.190% | -5.143% | 35.621% | 51.184% | -26.124% | -5.143% |
Comments
Smith & Nephew SNATS (SNN) had its "overweight" rating reaffirmed by Morgan Stanley.
Show more
Ratings data for SNN provided by MarketBeat
Smith & Nephew SNATS (SNN) had its "buy" rating reaffirmed by The Goldman Sachs Group, Inc..
Show more
Ratings data for SNN provided by MarketBeat
Smith & Nephew SNATS (SNN) was upgraded by Wall Street Zen from "buy" to "strong-buy".
Show more
Ratings data for SNN provided by MarketBeat